Free Trial

MicroVision (MVIS) Financials

MicroVision logo
$1.31 +0.13 (+11.02%)
Closing price 05/28/2025 04:00 PM Eastern
Extended Trading
$1.34 +0.03 (+2.67%)
As of 07:43 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for MicroVision

Annual Income Statements for MicroVision

This table shows MicroVision's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Net Income / (Loss) Attributable to Common Shareholders
-97 -83 -53
Consolidated Net Income / (Loss)
-97 -83 -53
Net Income / (Loss) Continuing Operations
-97 -83 -53
Total Pre-Tax Income
-96 -82 -53
Total Operating Income
-86 -89 -54
Total Gross Profit
-2.83 4.49 0.56
Total Revenue
4.70 7.26 0.66
Operating Revenue
4.70 7.26 0.66
Total Cost of Revenue
7.53 2.77 0.10
Operating Cost of Revenue
7.53 2.77 0.10
Total Operating Expenses
83 93 54
Selling, General & Admin Expense
29 37 24
Research & Development Expense
49 57 30
Impairment Charge
4.18 0.00 0.00
Other Special Charges / (Income)
0.14 -0.03 0.00
Total Other Income / (Expense), net
-11 7.18 0.80
Interest Expense
4.46 0.08 0.06
Other Income / (Expense), net
-6.43 7.26 0.86
Income Tax Expense
0.51 1.15 0.00
Weighted Average Basic Shares Outstanding
209.51M 182.80M 165.96M
Weighted Average Diluted Shares Outstanding
209.51M 182.80M 165.96M
Weighted Average Basic & Diluted Shares Outstanding
245.00M 195.27M 175.82M

Quarterly Income Statements for MicroVision

This table shows MicroVision's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders
-31 -16 -24 -26 -20 -23 -21 -19 -13 -13
Consolidated Net Income / (Loss)
-31 -16 -24 -26 -20 -23 -21 -19 -13 -13
Net Income / (Loss) Continuing Operations
-31 -16 -24 -26 -20 -23 -21 -19 -13 -13
Total Pre-Tax Income
-31 -15 -24 -26 -19 -23 -20 -19 -14 -13
Total Operating Income
-18 -16 -25 -27 -20 -24 -24 -21 -14 -13
Total Gross Profit
-2.47 -0.39 0.35 -0.32 4.20 0.42 -0.37 0.24 -0.03 -0.05
Total Revenue
1.65 0.19 1.90 0.96 5.10 1.05 0.33 0.78 - 0.00
Operating Revenue
1.65 0.19 1.90 0.96 5.10 1.05 0.33 0.78 - 0.00
Total Cost of Revenue
4.12 0.58 1.55 1.28 0.90 0.63 0.70 0.54 0.03 0.05
Operating Cost of Revenue
4.12 0.58 1.55 1.28 0.90 0.63 0.70 0.54 0.03 0.05
Total Operating Expenses
16 15 25 26 24 24 24 21 14 13
Selling, General & Admin Expense
5.92 6.60 7.75 9.08 9.52 8.74 9.69 8.74 6.38 5.52
Research & Development Expense
8.76 8.74 14 17 15 16 14 13 7.59 7.54
Total Other Income / (Expense), net
-13 0.30 0.79 0.63 0.63 0.64 3.57 2.35 0.48 0.25
Other Income / (Expense), net
-8.15 0.30 0.79 0.63 0.71 0.64 3.57 2.35 - 0.25
Income Tax Expense
0.08 0.11 0.08 0.23 0.48 0.21 0.28 0.18 - 0.00
Weighted Average Basic Shares Outstanding
209.51M 213.00M 208.67M 196.75M 182.80M 188.31M 177.30M 174.70M 165.96M 165.69M
Weighted Average Diluted Shares Outstanding
209.51M 213.00M 208.67M 196.75M 182.80M 188.31M 177.30M 174.70M 165.96M 165.69M
Weighted Average Basic & Diluted Shares Outstanding
245.00M 219.02M 212.75M 206.66M 195.27M 189.99M 187.78M 176.52M 175.82M 166.04M

Annual Cash Flow Statements for MicroVision

This table details how cash moves in and out of MicroVision's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Net Change in Cash & Equivalents
6.86 27 -62
Net Cash From Operating Activities
-69 -67 -38
Net Cash From Continuing Operating Activities
-69 -67 -38
Net Income / (Loss) Continuing Operations
-97 -83 -53
Consolidated Net Income / (Loss)
-97 -83 -53
Depreciation Expense
6.92 7.86 2.25
Amortization Expense
4.38 0.00 0.00
Non-Cash Adjustments To Reconcile Net Income
26 13 16
Changes in Operating Assets and Liabilities, net
-9.15 -5.36 -2.81
Net Cash From Investing Activities
2.67 22 -38
Net Cash From Continuing Investing Activities
2.67 22 -38
Purchase of Property, Plant & Equipment
-0.37 -1.94 -4.36
Acquisitions
-6.30 -11 -4.13
Purchase of Investments
-26 -42 -90
Sale and/or Maturity of Investments
35 77 61
Net Cash From Financing Activities
73 72 14
Net Cash From Continuing Financing Activities
73 72 14
Repayment of Debt
0.00 0.00 -0.39
Issuance of Debt
38 0.00 0.00
Issuance of Common Equity
35 72 14
Other Financing Activities, net
0.06 0.15 0.70
Effect of Exchange Rate Changes
-0.17 0.27 0.00

Quarterly Cash Flow Statements for MicroVision

This table details how cash moves in and out of MicroVision's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents
38 -10 -18 -3.05 -4.20 -13 39 5.46 -1.44 -15
Net Cash From Operating Activities
-15 -14 -19 -21 -17 -20 -17 -13 -8.40 -9.01
Net Cash From Continuing Operating Activities
-15 -14 -19 -21 -17 -20 -17 -13 -8.40 -9.00
Net Income / (Loss) Continuing Operations
-31 -16 -24 -26 -20 -23 -21 -19 -13 -13
Consolidated Net Income / (Loss)
-31 -16 -24 -26 -20 -23 -21 -19 -13 -13
Depreciation Expense
1.67 1.68 1.77 1.80 1.58 2.14 1.63 2.52 0.82 0.52
Non-Cash Adjustments To Reconcile Net Income
14 2.26 6.55 3.48 4.39 4.40 3.78 0.68 3.29 4.15
Changes in Operating Assets and Liabilities, net
-3.90 -2.51 -3.03 0.28 -2.81 -3.45 -1.44 2.34 0.96 -0.82
Net Cash From Investing Activities
6.50 3.58 -4.13 -3.28 0.44 2.70 12 6.25 -7.03 -6.28
Net Cash From Continuing Investing Activities
6.50 3.58 -4.13 -3.28 0.44 2.70 12 6.25 -7.03 -6.28
Purchase of Property, Plant & Equipment
-0.10 0.01 -0.17 -0.11 0.05 -0.50 -0.87 -0.62 -2.34 -0.89
Purchase of Investments
-0.50 -2.08 -16 -7.81 -15 -9.80 -13 -3.90 -26 -26
Sale and/or Maturity of Investments
7.10 5.66 15 7.90 15 13 27 22 26 20
Net Cash From Financing Activities
47 -0.02 5.15 21 12 4.74 43 13 14 0.31
Net Cash From Continuing Financing Activities
47 -0.02 5.15 21 12 4.74 43 13 14 0.31
Issuance of Common Equity
8.66 -0.02 5.15 21 12 4.74 43 13 14 -
Effect of Exchange Rate Changes
-0.30 0.11 0.06 -0.03 0.27 - - 0.00 - -

Annual Balance Sheets for MicroVision

This table presents MicroVision's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Total Assets
121 130 115
Total Current Assets
82 87 91
Cash & Equivalents
54 45 21
Restricted Cash
0.26 3.26 0.00
Short-Term Investments
20 29 62
Accounts Receivable
0.93 0.95 0.00
Inventories, net
2.29 3.87 1.86
Other Current Assets
4.29 4.89 6.44
Plant, Property, & Equipment, net
7.06 9.03 6.83
Total Noncurrent Assets
32 34 17
Intangible Assets
11 17 0.08
Other Noncurrent Operating Assets
21 17 17
Total Liabilities & Shareholders' Equity
121 130 115
Total Liabilities
72 34 25
Total Current Liabilities
46 21 11
Short-Term Debt
24 0.00 0.00
Accounts Payable
1.13 2.27 2.06
Accrued Expenses
2.54 15 2.06
Other Current Liabilities
18 3.29 2.71
Total Noncurrent Liabilities
26 13 14
Long-Term Debt
8.75 0.00 -
Capital Lease Obligations
16 13 -
Other Noncurrent Operating Liabilities
1.73 0.61 14
Commitments & Contingencies
0.00 0.00 0.00
Total Equity & Noncontrolling Interests
49 96 90
Total Preferred & Common Equity
49 96 90
Preferred Stock
0.00 0.00 0.00
Total Common Equity
49 96 90
Common Stock
911 861 772
Retained Earnings
-862 -765 -683
Accumulated Other Comprehensive Income / (Loss)
0.00 0.21 -0.13

Quarterly Balance Sheets for MicroVision

This table presents MicroVision's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 9/30/2024 6/30/2024 3/31/2024 9/30/2023 6/30/2023 3/31/2023 9/30/2022
Total Assets
88 103 124 136 149 123 109
Total Current Assets
53 67 82 91 103 77 88
Cash & Equivalents
17 27 44 49 62 23 22
Restricted Cash
0.27 0.07 0.07 3.26 3.26 3.26 -
Short-Term Investments
27 30 29 29 32 45 61
Accounts Receivable
0.23 1.97 1.12 0.74 0.82 0.51 -
Inventories, net
4.49 4.20 3.74 3.62 2.93 3.12 1.76
Other Current Assets
4.86 3.65 4.30 5.77 2.33 2.37 2.83
Plant, Property, & Equipment, net
7.67 8.13 8.55 9.46 9.95 10 4.55
Total Noncurrent Assets
28 29 33 35 35 36 17
Intangible Assets
13 13 17 18 18 19 0.09
Other Noncurrent Operating Assets
15 16 17 17 17 17 17
Total Liabilities & Shareholders' Equity
88 103 124 136 149 123 109
Total Liabilities
22 25 30 38 36 37 24
Total Current Liabilities
11 13 18 24 23 22 9.96
Short-Term Debt
0.00 0.00 5.14 8.55 8.48 - 0.00
Accounts Payable
1.49 1.45 2.16 2.29 1.89 3.63 1.52
Accrued Expenses
5.89 8.89 9.97 7.20 6.60 10 1.59
Current Deferred Revenue
0.18 0.17 0.21 4.96 5.73 - 4.60
Other Current Liabilities
3.05 2.14 0.27 1.06 0.00 8.11 2.25
Total Noncurrent Liabilities
12 12 13 14 13 15 14
Other Noncurrent Operating Liabilities
12 12 13 14 13 14 14
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
66 79 94 98 113 87 86
Total Preferred & Common Equity
66 79 94 98 113 87 86
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
66 79 94 98 113 87 86
Common Stock
897 894 885 844 835 788 755
Retained Earnings
-831 -816 -792 -746 -722 -702 -669
Accumulated Other Comprehensive Income / (Loss)
0.34 0.10 0.16 0.05 -0.01 0.06 -0.19

Annual Metrics And Ratios for MicroVision

This table displays calculated financial ratios and metrics derived from MicroVision's official financial filings.

Metric 2024 2023 2022
Period end date 12/31/2024 12/31/2023 12/31/2022
Growth Metrics
- - -
Revenue Growth
-35.31% 993.22% -73.44%
EBITDA Growth
-9.35% -45.23% -19.69%
EBIT Growth
-12.66% -53.91% -20.82%
NOPAT Growth
3.78% -64.92% -22.84%
Net Income Growth
-16.99% -56.04% -22.90%
EPS Growth
0.00% -40.63% -18.52%
Operating Cash Flow Growth
-2.16% -76.46% -29.30%
Free Cash Flow Firm Growth
40.98% -84.57% -35.15%
Invested Capital Growth
-27.69% 347.63% 420.36%
Revenue Q/Q Growth
-42.36% 236.38% -45.62%
EBITDA Q/Q Growth
-3.70% 2.79% -0.23%
EBIT Q/Q Growth
-8.69% 1.65% -0.98%
NOPAT Q/Q Growth
1.63% -7.10% -2.62%
Net Income Q/Q Growth
-13.35% -8.18% -1.63%
EPS Q/Q Growth
0.00% -4.65% 0.00%
Operating Cash Flow Q/Q Growth
2.17% -13.88% -0.65%
Free Cash Flow Firm Q/Q Growth
11.41% -6.69% -13.94%
Invested Capital Q/Q Growth
1.69% 23.42% 196.83%
Profitability Metrics
- - -
Gross Margin
-60.35% 61.81% 84.94%
EBITDA Margin
-1,717.40% -1,016.01% -7,648.04%
Operating Margin
-1,821.10% -1,224.34% -8,115.96%
EBIT Margin
-1,958.07% -1,124.34% -7,986.30%
Profit (Net Income) Margin
-2,063.78% -1,141.23% -7,995.63%
Tax Burden Percent
100.53% 101.40% 100.00%
Interest Burden Percent
104.85% 100.10% 100.12%
Effective Tax Rate
0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-220.74% -323.11% -1,559.77%
ROIC Less NNEP Spread (ROIC-NNEP)
-138.71% -295.05% -1,544.22%
Return on Net Nonoperating Assets (RNNOA)
86.67% 233.81% 1,507.33%
Return on Equity (ROE)
-134.07% -89.30% -52.44%
Cash Return on Invested Capital (CROIC)
-188.60% -450.06% -667.66%
Operating Return on Assets (OROA)
-73.33% -66.73% -43.25%
Return on Assets (ROA)
-77.29% -67.73% -43.30%
Return on Common Equity (ROCE)
-134.07% -89.30% -52.44%
Return on Equity Simple (ROE_SIMPLE)
-198.72% -86.47% -59.16%
Net Operating Profit after Tax (NOPAT)
-60 -62 -38
NOPAT Margin
-1,274.77% -857.04% -5,681.17%
Net Nonoperating Expense Percent (NNEP)
-82.03% -28.06% -15.55%
Return On Investment Capital (ROIC_SIMPLE)
-61.26% -57.33% -42.04%
Cost of Revenue to Revenue
160.35% 38.19% 15.06%
SG&A Expenses to Revenue
624.91% 505.43% 3,620.63%
R&D to Revenue
1,043.76% 781.20% 4,580.27%
Operating Expenses to Revenue
1,760.75% 1,286.16% 8,200.90%
Earnings before Interest and Taxes (EBIT)
-92 -82 -53
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-81 -74 -51
Valuation Ratios
- - -
Price to Book Value (P/BV)
5.88 5.28 4.35
Price to Tangible Book Value (P/TBV)
7.59 6.43 4.35
Price to Revenue (P/Rev)
61.10 69.62 587.62
Price to Earnings (P/E)
0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
11.46 14.01 43.73
Enterprise Value to Revenue (EV/Rev)
55.56 60.76 463.06
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00
Leverage & Solvency
- - -
Debt to Equity
1.00 0.13 0.00
Long-Term Debt to Equity
0.51 0.13 0.00
Financial Leverage
-0.62 -0.79 -0.98
Leverage Ratio
1.73 1.32 1.21
Compound Leverage Factor
1.82 1.32 1.21
Debt to Total Capital
50.10% 11.72% 0.00%
Short-Term Debt to Total Capital
24.81% 0.00% 0.00%
Long-Term Debt to Total Capital
25.28% 11.72% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00%
Common Equity to Total Capital
49.90% 88.28% 100.00%
Debt to EBITDA
-0.61 -0.17 0.00
Net Debt to EBITDA
0.32 0.87 0.00
Long-Term Debt to EBITDA
-0.31 -0.17 0.00
Debt to NOPAT
-0.82 -0.20 0.00
Net Debt to NOPAT
0.43 1.03 0.00
Long-Term Debt to NOPAT
-0.41 -0.20 0.00
Altman Z-Score
-9.69 -0.71 0.28
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00%
Liquidity Ratios
- - -
Current Ratio
1.79 4.23 7.97
Quick Ratio
1.65 3.64 7.24
Cash Flow Metrics
- - -
Free Cash Flow to Firm (FCFF)
-51 -87 -47
Operating Cash Flow to CapEx
-18,326.20% -3,467.18% -872.20%
Free Cash Flow to Firm to Interest Expense
-11.48 -1,083.22 -757.26
Operating Cash Flow to Interest Expense
-15.38 -838.63 -613.21
Operating Cash Flow Less CapEx to Interest Expense
-15.46 -862.81 -683.52
Efficiency Ratios
- - -
Asset Turnover
0.04 0.06 0.01
Accounts Receivable Turnover
5.01 0.00 0.00
Inventory Turnover
2.44 0.97 0.05
Fixed Asset Turnover
0.58 0.92 0.13
Accounts Payable Turnover
4.43 1.28 0.04
Days Sales Outstanding (DSO)
72.87 0.00 0.00
Days Inventory Outstanding (DIO)
149.49 377.57 6,644.83
Days Payable Outstanding (DPO)
82.48 285.21 10,302.13
Cash Conversion Cycle (CCC)
139.88 92.37 -3,657.30
Capital & Investment Metrics
- - -
Invested Capital
23 31 7.03
Invested Capital Turnover
0.17 0.38 0.27
Increase / (Decrease) in Invested Capital
-8.72 24 9.23
Enterprise Value (EV)
261 441 307
Market Capitalization
287 505 390
Book Value per Share
$0.22 $0.50 $0.54
Tangible Book Value per Share
$0.17 $0.41 $0.54
Total Capital
98 109 90
Total Debt
49 13 0.00
Total Long-Term Debt
25 13 0.00
Net Debt
-26 -64 -83
Capital Expenditures (CapEx)
0.37 1.94 4.36
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-14 -11 -3.13
Debt-free Net Working Capital (DFNWC)
61 66 80
Net Working Capital (NWC)
37 66 80
Net Nonoperating Expense (NNE)
37 21 15
Net Nonoperating Obligations (NNO)
-26 -64 -83
Total Depreciation and Amortization (D&A)
11 7.86 2.25
Debt-free, Cash-free Net Working Capital to Revenue
-302.30% -148.64% -470.93%
Debt-free Net Working Capital to Revenue
1,294.02% 912.67% 11,985.24%
Net Working Capital to Revenue
777.66% 912.67% 11,985.24%
Earnings Adjustments
- - -
Adjusted Basic Earnings per Share
$0.00 ($0.45) ($0.32)
Adjusted Weighted Average Basic Shares Outstanding
209.51M 182.80M 165.96M
Adjusted Diluted Earnings per Share
$0.00 ($0.45) ($0.32)
Adjusted Weighted Average Diluted Shares Outstanding
209.51M 182.80M 165.96M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
245.00M 195.27M 175.82M
Normalized Net Operating Profit after Tax (NOPAT)
-57 -62 -38
Normalized NOPAT Margin
-1,210.32% -857.37% -5,681.17%
Pre Tax Income Margin
-2,052.98% -1,125.44% -7,995.63%
Debt Service Ratios
- - -
EBIT to Interest Expense
-20.63 -1,020.20 -855.31
NOPAT to Interest Expense
-13.43 -777.66 -608.44
EBIT Less CapEx to Interest Expense
-20.71 -1,044.39 -925.61
NOPAT Less CapEx to Interest Expense
-13.52 -801.84 -678.74
Payout Ratios
- - -
Dividend Payout Ratio
0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for MicroVision

This table displays calculated financial ratios and metrics derived from MicroVision's official financial filings.

Metric Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics
- - - - - - - - - -
Revenue Growth
-67.65% -81.85% 477.51% 22.25% 0.00% 0.00% 4.78% 123.43% 0.00% -100.00%
EBITDA Growth
-41.67% 34.98% -18.03% -48.75% -33.64% -71.34% -41.92% -29.12% -8.01% -27.16%
EBIT Growth
-38.76% 33.75% -17.29% -38.38% -37.06% -80.98% -49.52% -43.60% -10.89% -27.63%
NOPAT Growth
7.12% 34.27% -3.06% -26.04% -42.12% -82.38% -74.85% -61.47% -10.89% -30.12%
Net Income Growth
-57.85% 33.88% -16.11% -38.29% -46.47% -82.62% -51.57% -44.49% -6.73% -36.98%
EPS Growth
0.00% 41.67% 8.33% -18.18% -25.00% -50.00% -50.00% -37.50% 0.00% 0.00%
Operating Cash Flow Growth
9.18% 30.89% -11.97% -53.98% -97.29% -126.23% -71.62% -23.61% -2.99% 9.59%
Free Cash Flow Firm Growth
89.01% 80.25% 60.40% 3.68% -101.68% -192.75% -139.47% -91.53% -47.85% -4.35%
Invested Capital Growth
-27.69% -12.24% -7.96% 65.98% 347.63% 976.57% 1,195.65% 4,772.73% 420.36% 214.11%
Revenue Q/Q Growth
768.42% -90.00% 98.74% -81.26% 387.20% 218.24% -57.93% 0.00% 0.00% -100.00%
EBITDA Q/Q Growth
-81.63% 37.79% 9.07% -37.28% 16.64% -12.93% -14.59% -23.90% -6.87% 6.46%
EBIT Q/Q Growth
-72.74% 35.38% 8.56% -35.39% 17.53% -14.40% -7.87% -34.66% -8.90% 5.49%
NOPAT Q/Q Growth
-17.61% 36.23% 7.78% -34.30% 16.77% 0.02% -12.78% -51.42% -6.82% 4.15%
Net Income Q/Q Growth
-100.78% 35.16% 9.06% -33.32% 15.90% -13.88% -8.31% -41.20% -4.86% 5.49%
EPS Q/Q Growth
0.00% 36.36% 15.38% -30.00% 16.67% 0.00% -9.09% -37.50% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
-6.85% 24.38% 10.24% -25.22% 18.69% -22.51% -23.44% -60.44% 6.76% 7.06%
Free Cash Flow Firm Q/Q Growth
46.46% 48.68% 47.01% 9.39% 3.75% -2.89% -28.89% -58.01% -39.71% 15.84%
Invested Capital Q/Q Growth
1.69% 1.95% -14.91% 2.94% 23.42% 6.92% 53.45% 121.05% 196.83% 28.68%
Profitability Metrics
- - - - - - - - - -
Gross Margin
-149.45% -206.84% 18.21% -33.58% 82.32% 40.31% -113.07% 30.43% 0.00% 0.00%
EBITDA Margin
-1,511.70% -7,227.89% -1,161.89% -2,539.64% -345.15% -2,017.29% -5,684.80% -2,087.21% 0.00% 0.00%
Operating Margin
-1,119.52% -8,266.32% -1,296.37% -2,793.93% -389.90% -2,282.24% -7,264.44% -2,709.85% 0.00% 0.00%
EBIT Margin
-1,613.15% -8,110.00% -1,255.05% -2,727.93% -376.04% -2,221.39% -6,179.33% -2,409.97% 0.00% 0.00%
Profit (Net Income) Margin
-1,888.18% -8,166.84% -1,259.47% -2,752.41% -386.92% -2,241.55% -6,264.13% -2,433.12% 0.00% 0.00%
Tax Burden Percent
100.26% 100.70% 100.35% 100.90% 102.47% 100.91% 101.37% 100.96% 99.67% 100.00%
Interest Burden Percent
116.74% 100.00% 100.00% 100.00% 100.42% 100.00% 100.00% 100.00% 96.60% 100.00%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-135.70% -1,968.88% -356.75% -703.23% -102.90% -247.38% -439.76% -262.12% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
-95.35% -1,961.10% -347.55% -692.27% -94.99% -238.73% -435.47% -257.30% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
59.58% 1,388.87% 264.29% 533.56% 75.27% 202.54% 381.31% 235.82% 0.00% 0.00%
Return on Equity (ROE)
-76.12% -580.02% -92.46% -169.66% -27.62% -44.83% -58.44% -26.30% 0.00% 0.00%
Cash Return on Invested Capital (CROIC)
-188.60% -241.13% -282.44% -369.25% -450.06% -582.80% -564.67% -738.76% -667.66% -1,739.39%
Operating Return on Assets (OROA)
-60.41% -589.38% -89.66% -163.89% -22.32% -39.08% -53.67% -21.92% 0.00% 0.00%
Return on Assets (ROA)
-70.71% -593.51% -89.98% -165.36% -22.96% -39.43% -54.40% -22.13% 0.00% 0.00%
Return on Common Equity (ROCE)
-76.12% -580.02% -92.46% -169.66% -27.62% -44.83% -58.44% -26.30% 0.00% 0.00%
Return on Equity Simple (ROE_SIMPLE)
0.00% -129.83% -118.73% -96.08% 0.00% -77.94% -58.63% -68.12% 0.00% -61.01%
Net Operating Profit after Tax (NOPAT)
-13 -11 -17 -19 -14 -17 -17 -15 -9.80 -9.17
NOPAT Margin
-783.66% -5,786.42% -907.46% -1,955.75% -272.93% -1,597.56% -5,085.11% -1,896.89% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)
-40.35% -7.78% -9.20% -10.96% -7.91% -8.64% -4.29% -4.82% -3.72% -3.54%
Return On Investment Capital (ROIC_SIMPLE)
-13.23% - - - -12.83% - - - -10.92% -
Cost of Revenue to Revenue
249.45% 306.84% 81.79% 133.58% 17.68% 59.69% 213.07% 69.57% 0.00% 0.00%
SG&A Expenses to Revenue
358.97% 3,473.16% 407.68% 949.58% 186.57% 835.05% 2,945.90% 1,117.26% 0.00% 0.00%
R&D to Revenue
531.15% 4,597.89% 747.58% 1,810.77% 285.83% 1,488.44% 4,210.03% 1,623.02% 0.00% 0.00%
Operating Expenses to Revenue
970.06% 8,059.47% 1,314.58% 2,760.36% 472.22% 2,322.54% 7,151.37% 2,740.28% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)
-27 -15 -24 -26 -19 -23 -20 -19 -14 -13
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-25 -14 -22 -24 -18 -21 -19 -16 -13 -12
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
5.88 3.68 2.78 3.83 5.28 4.19 7.19 5.42 4.35 6.98
Price to Tangible Book Value (P/TBV)
7.59 4.55 3.34 4.66 6.43 5.11 8.58 6.95 4.35 6.99
Price to Revenue (P/Rev)
61.10 29.77 24.33 48.34 69.62 190.57 727.69 428.32 587.62 489.40
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
11.46 8.89 7.39 11.29 14.01 13.27 30.18 25.63 43.73 217.10
Enterprise Value to Revenue (EV/Rev)
55.56 24.43 18.03 39.19 60.76 156.85 647.90 363.54 463.06 421.21
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
1.00 0.00 0.00 0.05 0.13 0.09 0.08 0.00 0.00 0.00
Long-Term Debt to Equity
0.51 0.00 0.00 0.00 0.13 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.62 -0.71 -0.76 -0.77 -0.79 -0.85 -0.88 -0.92 -0.98 -1.00
Leverage Ratio
1.73 1.37 1.32 1.37 1.32 1.33 1.24 1.27 1.21 1.17
Compound Leverage Factor
2.03 1.37 1.32 1.37 1.32 1.33 1.24 1.27 1.17 1.17
Debt to Total Capital
50.10% 0.00% 0.00% 5.19% 11.72% 8.01% 7.01% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
24.81% 0.00% 0.00% 5.19% 0.00% 8.01% 7.01% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
25.28% 0.00% 0.00% 0.00% 11.72% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
49.90% 100.00% 100.00% 94.81% 88.28% 91.99% 92.99% 100.00% 100.00% 100.00%
Debt to EBITDA
-0.61 0.00 0.00 -0.06 -0.17 -0.11 -0.13 0.00 0.00 0.00
Net Debt to EBITDA
0.32 0.00 0.00 0.83 0.87 0.96 1.33 0.00 0.00 1.64
Long-Term Debt to EBITDA
-0.31 0.00 0.00 0.00 -0.17 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
-0.82 0.00 0.00 -0.08 -0.20 -0.15 -0.17 0.00 0.00 0.00
Net Debt to NOPAT
0.43 0.00 0.00 1.03 1.03 1.25 1.75 0.00 0.00 2.26
Long-Term Debt to NOPAT
-0.41 0.00 0.00 0.00 -0.20 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
-7.91 -6.60 -5.77 -1.84 0.88 -1.09 6.82 -0.26 1.40 7.00
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
1.79 5.00 5.26 4.64 4.23 3.80 4.55 3.48 7.97 8.82
Quick Ratio
1.65 4.09 4.64 4.18 3.64 3.27 4.17 3.08 7.24 8.36
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-4.22 -7.87 -15 -29 -38 -40 -39 -30 -19 -14
Operating Cash Flow to CapEx
-14,617.48% 0.00% -11,225.30% -18,209.65% 0.00% -4,102.21% -1,915.07% -2,192.20% -358.80% -1,013.72%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.04 0.07 0.07 0.06 0.06 0.02 0.01 0.01 0.01 0.01
Accounts Receivable Turnover
5.01 16.76 6.45 9.14 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
2.44 1.07 1.22 1.02 0.97 0.71 0.56 0.26 0.05 0.08
Fixed Asset Turnover
0.58 0.95 1.00 0.79 0.92 0.31 0.17 0.16 0.13 0.33
Accounts Payable Turnover
4.43 2.28 2.61 1.21 1.28 1.00 0.80 0.23 0.04 0.08
Days Sales Outstanding (DSO)
72.87 21.77 56.57 39.95 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
149.49 342.59 298.83 356.88 377.57 515.76 657.44 1,406.11 6,644.83 4,672.00
Days Payable Outstanding (DPO)
82.48 159.88 139.79 301.48 285.21 365.67 455.91 1,582.05 10,302.13 4,622.80
Cash Conversion Cycle (CCC)
139.88 204.49 215.62 95.35 92.37 150.09 201.54 -175.94 -3,657.30 49.20
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
23 22 22 26 31 26 24 16 7.03 2.37
Invested Capital Turnover
0.17 0.34 0.39 0.36 0.38 0.15 0.09 0.14 0.27 8.33
Increase / (Decrease) in Invested Capital
-8.72 -3.12 -1.90 10 24 23 22 15 9.23 4.45
Enterprise Value (EV)
261 199 162 291 441 338 720 398 307 514
Market Capitalization
287 243 219 359 505 411 808 469 390 598
Book Value per Share
$0.22 $0.31 $0.38 $0.48 $0.50 $0.52 $0.64 $0.49 $0.54 $0.52
Tangible Book Value per Share
$0.17 $0.25 $0.32 $0.40 $0.41 $0.43 $0.53 $0.38 $0.54 $0.52
Total Capital
98 66 79 99 109 107 121 87 90 86
Total Debt
49 0.00 0.00 5.14 13 8.55 8.48 0.00 0.00 0.00
Total Long-Term Debt
25 0.00 0.00 0.00 13 0.00 0.00 0.00 0.00 0.00
Net Debt
-26 -43 -57 -68 -64 -73 -89 -71 -83 -83
Capital Expenditures (CapEx)
0.10 -0.01 0.17 0.11 -0.05 0.50 0.87 0.62 2.34 0.89
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-14 -1.04 -2.83 -3.45 -11 -5.39 -8.08 -16 -3.13 -5.37
Debt-free Net Working Capital (DFNWC)
61 42 54 70 66 76 89 55 80 78
Net Working Capital (NWC)
37 42 54 65 66 67 81 55 80 78
Net Nonoperating Expense (NNE)
18 4.52 6.69 7.62 5.81 6.74 3.88 4.19 3.68 3.68
Net Nonoperating Obligations (NNO)
-26 -43 -57 -68 -64 -73 -89 -71 -83 -83
Total Depreciation and Amortization (D&A)
1.67 1.68 1.77 1.80 1.58 2.14 1.63 2.52 0.82 0.52
Debt-free, Cash-free Net Working Capital to Revenue
-302.30% -12.72% -31.45% -46.47% -148.64% -249.91% -726.82% -1,474.36% -470.93% -439.56%
Debt-free Net Working Capital to Revenue
1,294.02% 520.88% 598.88% 937.51% 912.67% 3,517.75% 8,016.29% 5,003.19% 11,985.24% 6,379.28%
Net Working Capital to Revenue
777.66% 520.88% 598.88% 868.41% 912.67% 3,121.46% 7,252.66% 5,003.19% 11,985.24% 6,379.28%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 ($0.07) ($0.11) ($0.13) ($0.10) ($0.12) ($0.12) ($0.11) ($0.08) $0.00
Adjusted Weighted Average Basic Shares Outstanding
209.51M 213.00M 208.67M 196.75M 182.80M 188.31M 177.30M 174.70M 165.96M 166.04M
Adjusted Diluted Earnings per Share
$0.00 ($0.07) ($0.11) ($0.13) ($0.10) ($0.12) ($0.12) ($0.11) ($0.08) $0.00
Adjusted Weighted Average Diluted Shares Outstanding
209.51M 213.00M 208.67M 196.75M 182.80M 188.31M 177.30M 174.70M 165.96M 166.04M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
245.00M 219.02M 212.75M 206.66M 195.27M 189.99M 187.78M 176.52M 175.82M 166.04M
Normalized Net Operating Profit after Tax (NOPAT)
-13 -11 -15 -19 -14 -17 -17 -15 -9.80 -9.17
Normalized NOPAT Margin
-783.66% -5,794.53% -795.94% -1,955.75% -272.93% -1,598.23% -5,088.30% -1,896.89% 0.00% 0.00%
Pre Tax Income Margin
-1,883.27% -8,110.00% -1,255.05% -2,727.93% -377.61% -2,221.39% -6,179.33% -2,409.97% 0.00% 0.00%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Frequently Asked Questions About MicroVision's Financials

When does MicroVision's financial year end?

According to the most recent income statement we have on file, MicroVision's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has MicroVision's net income changed over the last 2 years?

MicroVision's net income appears to be on an upward trend, with a most recent value of -$96.92 million in 2024, rising from -$53.09 million in 2022. The previous period was -$82.84 million in 2023. See where experts think MicroVision is headed by visiting MicroVision's forecast page.

What is MicroVision's operating income?
MicroVision's total operating income in 2024 was -$85.52 million, based on the following breakdown:
  • Total Gross Profit: -$2.83 million
  • Total Operating Expenses: $82.69 million
How has MicroVision revenue changed over the last 2 years?

Over the last 2 years, MicroVision's total revenue changed from $664 thousand in 2022 to $4.70 million in 2024, a change of 607.2%.

How much debt does MicroVision have?

MicroVision's total liabilities were at $72.39 million at the end of 2024, a 114.0% increase from 2023, and a 186.6% increase since 2022.

How much cash does MicroVision have?

In the past 2 years, MicroVision's cash and equivalents has ranged from $20.54 million in 2022 to $54.49 million in 2024, and is currently $54.49 million as of their latest financial filing in 2024.

How has MicroVision's book value per share changed over the last 2 years?

Over the last 2 years, MicroVision's book value per share changed from 0.54 in 2022 to 0.22 in 2024, a change of -58.8%.



This page (NASDAQ:MVIS) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners